Jason Giffi, DO, DABOM a board-certified physician specializing in obesity medicine, an Ironman triathlete, and a certified personal trainer
Tirzepatide with B12 is available from some compounding pharmacies as a combination product, and semaglutide with B12 functions similarly
Mounjaro, which was approved for diabetes in May 2022 (and for weight loss under the name Zepbound in November 2023), reached 370,203 Medicare beneficiaries in 2023
If approved, cagrilintide/semaglutide would be the first amylin/GLP-1 combination for weight management
Human and human-cell studies show it increases myotube nuclei, myosin content, and anabolic signaling, supporting faster muscle recovery and growth